Sign in
4

Changes in Ownership

MAIA Biotechnology, Inc. Filed Acc 0001127602-25-000375

Options or other derivatives

  • Director acquired 10,225 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Theagene Jean-Manasse · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-12-31 Grant or award : show line 1 in the form Stock Options +10,225 10,225 D
Loading xslF345X05/form4.xml…